ONTX RSI Chart
Last 7 days
1.5%
Last 30 days
-2.9%
Last 90 days
-1.5%
Trailing 12 Months
-45%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 226.0K | 0 | 0 | 0 |
2023 | 226.0K | 226.0K | 226.0K | 226.0K |
2022 | 226.0K | 226.0K | 226.0K | 226.0K |
2021 | 235.0K | 236.0K | 227.0K | 226.0K |
2020 | 2.2M | 201.0K | 204.0K | 231.0K |
2019 | 1.5M | 1.7M | 1.9M | 2.2M |
2018 | 1.1M | 1.3M | 1.3M | 1.2M |
2017 | 4.3M | 2.4M | 817.0K | 787.0K |
2016 | 12.8M | 14.9M | 15.0M | 5.5M |
2015 | 467.0K | 465.0K | 2.0M | 11.5M |
2014 | 4.1M | 3.6M | 2.6M | 800.0K |
2013 | 46.8M | 47.5M | 5.8M | 4.8M |
2012 | 12.7M | 23.8M | 35.0M | 46.2M |
2011 | 0 | 0 | 0 | 1.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 14, 2024 | fruchtman steven m | sold (taxes) | -7,854 | 0.9 | -8,727 | president, chief executive off |
Mar 14, 2024 | guerin mark patrick | sold (taxes) | -2,331 | 0.9 | -2,591 | cfo and coo |
Mar 13, 2024 | fruchtman steven m | acquired | - | - | 23,111 | president, chief executive off |
Mar 13, 2024 | guerin mark patrick | acquired | - | - | 8,666 | cfo and coo |
Feb 07, 2024 | guerin mark patrick | sold (taxes) | -1,636 | 0.67 | -2,443 | cfo and coo |
Feb 07, 2024 | fruchtman steven m | acquired | - | - | 21,320 | president, chief executive off |
Feb 07, 2024 | guerin mark patrick | acquired | - | - | 6,900 | cfo and coo |
Feb 07, 2024 | fruchtman steven m | sold (taxes) | -6,172 | 0.67 | -9,212 | president, chief executive off |
Aug 03, 2023 | fruchtman steven m | sold (taxes) | -4,791 | 1.01 | -4,744 | president, chief executive off |
Aug 03, 2023 | guerin mark patrick | sold (taxes) | -1,450 | 1.02 | -1,422 | cfo and coo |
Which funds bought or sold ONTX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | unchanged | - | 13,958 | 53,318 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | new | - | 37,187 | 37,187 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -67.84 | - | - | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | reduced | -3.57 | 8,994 | 38,367 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | sold off | -100 | -11,549 | - | -% |
May 15, 2024 | TWO SIGMA ADVISERS, LP | reduced | -6.28 | 15,666 | 73,797 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -1.75 | 874 | 3,522 | -% |
May 15, 2024 | Vermillion & White Wealth Management Group, LLC | unchanged | - | 1,357 | 5,184 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -506 | - | -% |
May 15, 2024 | MORGAN STANLEY | unchanged | - | 4,986 | 19,044 | -% |
Unveiling Onconova Therapeutics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Onconova Therapeutics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Onconova Therapeutics Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 0% | 56,000 | 56,000 | 57,000 | 57,000 | 56,000 | 56,000 | 57,000 | 57,000 | 56,000 | 56,000 | 57,000 | 57,000 | 56,000 | 57,000 | 66,000 | 56,000 | 52,000 | 30,000 | 63,000 | 2,022,000 | 1,040,500 |
Operating Expenses | 16.6% | 5,268,000 | 4,518,000 | 5,146,000 | 4,667,000 | 6,193,000 | 5,790,000 | 5,698,000 | 4,177,000 | 4,188,000 | 3,819,000 | 4,047,000 | 4,702,000 | 4,154,000 | 6,312,000 | 6,340,000 | 7,395,000 | 5,177,000 | 5,757,500 | 5,161,000 | 5,655,000 | 7,309,000 |
S&GA Expenses | -100.0% | - | 2,084,000 | 2,686,000 | 2,211,000 | 2,113,000 | 2,017,000 | 2,105,000 | 2,139,000 | 2,186,000 | 2,074,000 | 2,284,000 | 2,850,000 | 2,217,000 | 1,778,000 | 2,147,000 | 2,594,000 | 1,807,000 | 1,711,000 | 1,640,000 | 1,760,000 | 3,234,000 |
R&D Expenses | -21.4% | 1,912,000 | 2,434,000 | 2,460,000 | 2,456,000 | 4,080,000 | 3,773,000 | 3,593,000 | 2,038,000 | 2,002,000 | 1,745,000 | 1,763,000 | 1,852,000 | 1,937,000 | 4,534,000 | 4,193,000 | 4,801,000 | 3,370,000 | 4,046,500 | 3,521,000 | 3,895,000 | 4,075,000 |
EBITDA Margin | 0.0% | -83.77 | -83.77 | -83.83 | -83.84 | -83.84 | -83.84 | -71.45 | -71.45 | -71.45 | -71.45 | -110 | -106 | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 68,000 |
EBT Margin | 0% | -83.84 | -83.84 | -83.91 | -83.91 | -83.91 | -83.91 | -71.52 | -71.52 | -71.52 | -71.52 | -110 | -106 | - | - | - | - | - | - | - | - | - |
Net Income | -19.1% | -4,983,000 | -4,184,000 | -4,739,000 | -4,250,000 | -5,775,000 | -5,420,000 | -5,398,000 | -4,024,000 | -4,122,000 | -3,764,000 | -3,453,000 | -4,231,000 | -4,715,000 | -6,429,000 | -6,241,000 | -7,395,000 | -5,092,000 | -5,747,000 | -4,595,000 | -3,561,000 | -7,600,000 |
Net Income Margin | 4.2% | -80.34 | -83.84 | -89.31 | -92.23 | -91.23 | -83.91 | -76.58 | -67.98 | -68.89 | -71.52 | -82.94 | -91.59 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 0.1% | -4,424,000 | -4,430,000 | -4,469,000 | -4,490,000 | -4,543,000 | -3,884,000 | -3,900,000 | -4,214,000 | -4,296,000 | -4,265,000 | -4,267,000 | -4,307,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -19.9% | 18.00 | 23.00 | 27.00 | 30.00 | 35.00 | 39.00 | 44.00 | 48.00 | 51.00 | 55.00 | 60.00 | 44.00 | 49.00 | 20.00 | 25.00 | 28.00 | 32.00 | 24.00 | 6.00 | 9.00 | 11.00 |
Current Assets | -19.9% | 18.00 | 23.00 | 27.00 | 30.00 | 35.00 | 39.00 | 44.00 | 48.00 | 51.00 | 55.00 | 60.00 | 44.00 | 49.00 | 20.00 | 25.00 | 28.00 | 32.00 | 23.00 | 6.00 | 8.00 | 11.00 |
Cash Equivalents | -21.3% | 16.00 | 21.00 | 25.00 | 30.00 | 34.00 | 39.00 | 43.00 | 47.00 | 51.00 | 55.00 | 59.00 | 44.00 | 48.00 | 19.00 | 24.00 | 27.00 | 31.00 | 23.00 | 5.00 | 6.00 | 10.00 |
Net PPE | -18.2% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | 1.2% | 12.00 | 12.00 | 13.00 | 12.00 | 12.00 | 11.00 | 10.00 | 10.00 | 9.00 | 9.00 | 10.00 | 11.00 | 12.00 | 14.00 | 13.00 | 13.00 | 11.00 | 12.00 | 12.00 | 13.00 | 13.00 |
Current Liabilities | 2.2% | 9.00 | 9.00 | 10.00 | 9.00 | 9.00 | 8.00 | 7.00 | 6.00 | 6.00 | 6.00 | 7.00 | 7.00 | 7.00 | 10.00 | 9.00 | 9.00 | 7.00 | 8.00 | 8.00 | 9.00 | 8.00 |
Shareholder's Equity | -43.6% | 6.00 | 11.00 | 15.00 | 19.00 | 23.00 | 28.00 | 33.00 | 38.00 | 42.00 | 46.00 | 50.00 | 33.00 | 37.00 | 6.00 | 12.00 | 16.00 | 21.00 | 12.00 | - | - | - |
Retained Earnings | -1.0% | -487 | -482 | -478 | -473 | -469 | -463 | -458 | -452 | -448 | -444 | -440 | -437 | -433 | -428 | -422 | -415 | -408 | -403 | -397 | -393 | -389 |
Additional Paid-In Capital | 0.1% | 493 | 493 | 493 | 492 | 492 | 492 | 491 | 491 | 491 | 491 | 490 | 470 | 468 | 435 | 432 | 430 | 428 | 414 | 392 | 388 | 388 |
Shares Outstanding | 20.5% | 25.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 15.00 | 16.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 25.00 | - | - | - | 28.00 | - | - | - | 109* | - | - | - | 98.00 | - | - | - | 16.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 0.1% | -4,424 | -4,430 | -4,469 | -4,490 | -4,543 | -3,884 | -3,900 | -4,214 | -4,296 | -4,265 | -4,267 | -4,307 | -6,648 | -5,468 | -5,763 | -5,381 | -6,463 | -5,360 | -3,961 | -4,909 | -6,601 |
Share Based Compensation | 0.3% | 333 | 332 | 360 | 273 | 336 | 330 | 305 | 241 | 296 | 261 | 190 | 60.00 | 65.00 | 94.00 | 90.00 | 92.00 | 93.00 | 98.00 | 145 | 155 | 650 |
Cashflow From Investing | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | - | - | - |
Cashflow From Financing | - | - | - | - | - | - | - | - | - | - | -35.00 | 19,944 | 7.00 | 35,644 | 279 | 2,718 | 1,581 | 14,779 | 23,255 | 2,969 | 391 | 33.00 |
Condensed Consolidated Statements of Operations (unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Condensed Consolidated Statements of Operations (unaudited) | ||
Revenue | $ 56,000 | $ 56,000 |
Operating expenses: | ||
General and administrative | 3,356,000 | 2,113,000 |
Research and development | 1,912,000 | 4,080,000 |
Total operating expenses | 5,268,000 | 6,193,000 |
Loss from operations | (5,212,000) | (6,137,000) |
Other income, net | 229,000 | 362,000 |
Net loss | $ (4,983,000) | $ (5,775,000) |
Net loss per share, basic (in dollars per share) | $ (0.24) | $ (0.28) |
Net loss per share, diluted (in dollars per share) | $ (0.24) | $ (0.28) |
Basic weighted average shares outstanding (in shares) | 21,043,458 | 20,960,171 |
Diluted weighted average shares outstanding (in shares) | 21,043,458 | 20,960,171 |
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 16,390,000 | $ 20,821,000 |
Receivables | 18,000 | 18,000 |
Prepaid expenses and other current assets | 1,745,000 | 1,821,000 |
Total current assets | 18,153,000 | 22,660,000 |
Property and equipment, net | 18,000 | 22,000 |
Other non-current assets | 1,000 | 1,000 |
Total assets | 18,172,000 | 22,683,000 |
Current liabilities: | ||
Accounts payable | 6,568,000 | 5,619,000 |
Accrued expenses and other current liabilities | 2,628,000 | 3,375,000 |
Deferred revenue | 226,000 | 226,000 |
Total current liabilities | 9,422,000 | 9,220,000 |
Deferred revenue, non-current | 2,735,000 | 2,791,000 |
Total liabilities | 12,157,000 | 12,011,000 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Preferred stock, $0.01 par value, 5,000,000 shares authorized, none issued and outstanding at March 31, 2024 and December 31, 2023 | ||
Common stock, $0.01 par value, 125,000,000 shares authorized, 21,085,935 and 21,003,409 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 211,000 | 210,000 |
Additional paid in capital | 493,448,000 | 493,116,000 |
Accumulated deficit | (487,614,000) | (482,631,000) |
Accumulated other comprehensive loss | (30,000) | (23,000) |
Total stockholders' equity | 6,015,000 | 10,672,000 |
Total liabilities and stockholders' equity | $ 18,172,000 | $ 22,683,000 |